Kim Yoon-Chul, Kim Sung Mok, Choe Yeon Hyeon
Clinical Research Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Department of Radiology and HVSI Imaging Center, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Comput Biol Med. 2016 Apr 1;71:162-73. doi: 10.1016/j.compbiomed.2016.02.014. Epub 2016 Mar 2.
Recently there have been several clinical MR perfusion studies in patients with hypertrophic cardiomyopathy (HCM) who may suffer from myocardial ischemia due to coronary microvascular dysfunction. In these studies, data analysis relied on a manual procedure of tracing epicardial and endocardial borders. The goal of this work is to develop and validate a robust semi-automated analysis method for myocardial perfusion quantification in clinical HCM data.
Dynamic multi-slice stress perfusion MRI data were acquired from 18 HCM patients. The proposed semi-automated method required user input of two landmark selections: LV center point and RV insertion point. Automated segmentations of the endocardial and epicardial borders were performed in three short-axis slices using distance regularized level set evolution on RV, LV, and myocardial enhancement frames.
The proposed automated epicardial border detection method resulted in average radial distance errors of 7.5%, 9.5%, and 11.6% in basal, mid, and apical slices, respectively, when compared to manual tracing of the borders as a reference. In linear regression analysis, the highest correlation of myocardial upslope measurements was observed between the manual method and the proposed method in the anterolateral section (r=0.964), and the lowest correlation was observed in the inferoseptal section (r=0.866).
The proposed semi-automated method for myocardial MR perfusion quantification is feasible in HCM patients who typically show (1) irregular myocardial shape and (2) low image contrast between the myocardium and its surrounding regions due to coronary microvascular disease.